These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27594295)

  • 21. Design, synthesis, and pharmacological evaluation of fluorinated azoles as anti-tubercular agents.
    Gholap S; Tambe M; Nawale L; Sarkar D; Sangshetti J; Damale M
    Arch Pharm (Weinheim); 2018 Feb; 351(2):. PubMed ID: 29292534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives.
    Peng CT; Gao C; Wang NY; You XY; Zhang LD; Zhu YX; Xv Y; Zuo WQ; Ran K; Deng HX; Lei Q; Xiao KJ; Yu LT
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1373-6. PubMed ID: 25754492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substituted 4-methylquinolines as a new class of anti-tuberculosis agents.
    Jain R; Vaitilingam B; Nayyar A; Palde PB
    Bioorg Med Chem Lett; 2003 Mar; 13(6):1051-4. PubMed ID: 12643909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, biological evaluation of substituted benzofurans as DNA gyraseB inhibitors of Mycobacterium tuberculosis.
    Renuka J; Reddy KI; Srihari K; Jeankumar VU; Shravan M; Sridevi JP; Yogeeswari P; Babu KS; Sriram D
    Bioorg Med Chem; 2014 Sep; 22(17):4924-34. PubMed ID: 25129171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, tuberculosis inhibitory activity, and SAR study of N-substituted-phenyl-1,2,3-triazole derivatives.
    Costa MS; Boechat N; Rangel EA; da Silva Fde C; de Souza AM; Rodrigues CR; Castro HC; Junior IN; Lourenço MC; Wardell SM; Ferreira VF
    Bioorg Med Chem; 2006 Dec; 14(24):8644-53. PubMed ID: 16949290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and anti-mycobacterial activity of 4-(4-phenyl-1H-1,2,3-triazol-1-yl)salicylhydrazones: revitalizing an old drug.
    Abdu-Allah HH; Youssif BG; Abdelrahman MH; Abdel-Hamid MK; Reshma RS; Yogeeswari P; Aboul-Fadl T; Sriram D
    Arch Pharm Res; 2017 Feb; 40(2):168-179. PubMed ID: 28028696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of novel 5-aryl-2-thio-1,3,4-oxadiazoles and the study of their structure-anti-mycobacterial activities.
    Macaev F; Rusu G; Pogrebnoi S; Gudima A; Stingaci E; Vlad L; Shvets N; Kandemirli F; Dimoglo A; Reynolds R
    Bioorg Med Chem; 2005 Aug; 13(16):4842-50. PubMed ID: 15993090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and antitubercular screening of [(2-chloroquinolin-3-yl)methyl] thiocarbamide derivatives.
    Kumar S; Upmanyu N; Afzal O; Bawa S
    Chem Biol Drug Des; 2014 Nov; 84(5):522-30. PubMed ID: 24750991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and antitubercular activity of new 1,3,4-oxadiazoles bearing pyridyl and thiazolyl scaffolds.
    Dhumal ST; Deshmukh AR; Bhosle MR; Khedkar VM; Nawale LU; Sarkar D; Mane RA
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3646-51. PubMed ID: 27301367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, Synthesis, and Characterization of Some Hybridized Pyrazolone Pharmacophore Analogs against Mycobacterium tuberculosis.
    Krishnasamy SK; Namasivayam V; Mathew S; Eakambaram RS; Ibrahim IA; Natarajan A; Palaniappan S
    Arch Pharm (Weinheim); 2016 May; 349(5):383-97. PubMed ID: 27135906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do new N-substituted 3-amino-4-phenyl-5-oxo-pyrazolinecarboxamide derivatives exhibit antitubercular potential?
    Swatko-Ossor M; Klimek K; Belcarz A; Kaczor AA; Pitucha M; Ginalska G
    Eur J Pharm Sci; 2018 Aug; 121():155-165. PubMed ID: 29802898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and antitubercular evaluation of novel series of N-[4-(piperazin-1-yl)phenyl]cinnamamide derivatives.
    Patel KN; Telvekar VN
    Eur J Med Chem; 2014 Mar; 75():43-56. PubMed ID: 24530490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toward antituberculosis drugs: in silico screening of synthetic compounds against Mycobacterium tuberculosisl,d-transpeptidase 2.
    Billones JB; Carrillo MC; Organo VG; Macalino SJ; Sy JB; Emnacen IA; Clavio NA; Concepcion GP
    Drug Des Devel Ther; 2016; 10():1147-57. PubMed ID: 27042006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and antitubercular activity of amino alcohol fused spirochromone conjugates.
    Mujahid M; Gonnade RG; Yogeeswari P; Sriram D; Muthukrishnan M
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1416-9. PubMed ID: 23357635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and optimization of a new series of anti-tubercular quinazolinones.
    Couturier C; Lair C; Pellet A; Upton A; Kaneko T; Perron C; Cogo E; Menegotto J; Bauer A; Scheiper B; Lagrange S; Bacqué E
    Bioorg Med Chem Lett; 2016 Nov; 26(21):5290-5299. PubMed ID: 27671498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and characterization of novel hydrazide-hydrazones and the study of their structure-antituberculosis activity.
    Bedia KK; Elçin O; Seda U; Fatma K; Nathaly S; Sevim R; Dimoglo A
    Eur J Med Chem; 2006 Nov; 41(11):1253-61. PubMed ID: 16919372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and antitubercular evaluation of novel series of 3-benzofuran-5-aryl-1-pyrazolyl-pyridylmethanone and 3-benzofuran-5-aryl-1-pyrazolylcarbonyl-4-oxo-naphthyridin analogs.
    Manna K; Agrawal YK
    Eur J Med Chem; 2010 Sep; 45(9):3831-9. PubMed ID: 20576327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting HIV-TB coinfection by developing novel piperidin-4-substituted imines: Design, synthesis, in vitro and in silico studies.
    Kumar A; Revathi R; Sriram D; Curreli F; Debnath AK; Pai KS; Kini SG
    Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800358. PubMed ID: 31066103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and biological evaluation of (E)-5-styryl-1,2,4-oxadiazoles as anti-tubercular agents.
    Atmaram Upare A; Gadekar PK; Sivaramakrishnan H; Naik N; Khedkar VM; Sarkar D; Choudhari A; Mohana Roopan S
    Bioorg Chem; 2019 May; 86():507-512. PubMed ID: 30776681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.